Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/26/17 → 10/26/20 |
Funding
- La Jolla Pharmaceutical Company (Prot #LJ501-EAP01)
Prot #LJ501-EAP01: Expanded Access for LJPC-501 (Angiotensin II)
- Wunderink, Richard G (PD/PI)
Project: Research project